Fantastic talk from ⁦Gargi Banerjee⁩ at #EAN2025 on central amyloid angiopathy. Great to hear how role of inflammation is opening up diagnostics and even treatment

European Headache Federation EMHA- European Migraine and Headache Alliance Eino Solje Katariina Suomu Muistiliitto ry Suomen musiikkiterapiayhdistys ry Multidisciplinary care teams and human contact are essential in #Parkinsons says Amelia Hursey (Parkinson's Europe 🌷). So is the 🧠 health mantra shared by Kailash Bhatia, : SEAES (Sleep, Exercice, Avoidance of head injury, Environment, Social interactions)

Kailash Bhatia, Vanisha Solanki Kam Rai

📈 Trending article by Bombaci et al. "Peripherin: A Novel Early Diagnostic and Prognostic Plasmatic Biomarker in Amyotrophic Lateral Sclerosis" 📖 Read now: onlinelibrary.wiley.com/doi/10.1111/en… #Neurology #ALS #Biomarkers #MND European Academy of Neurology @Wileyneuro

The Multiple System Atrophy (MSA) Trust receives no government support. The Trust relies entirely on charitable donations to fund our support services as well as research into finding the cause and cure for MSA. Please consider making a donation here- msatrust.org.uk/get-involved/d…

‘Non motor’ is a marketing ploy like lifestyle medicine. I suggest we get rid of it and talk of ‘symptoms’ and only include those that have strong epidemiological/ pathological evidence linking them to Parkinsons disease like constipation and seborrhoea. Rub out the gimmicks!

We are looking for a research assistant to join the qMAP-PD project, using quantitative MRI to develop diagnostic tools & biomarkers for Parkinson's, based at the Functional Imaging Laboratory. Deadline 14th September: Apply here: ucl.ac.uk/work-at-ucl/se… MovementDisordersUCL

"A true privilege to witness in Mexico City a master of neurological semiology. An extraordinary demonstration of clinical expertise and diagnostic reasoning — a priceless learning experience." Kailash Bhatia,

Wonderful Queen Square Basal Ganglia Club Meeting on Parkinsonian Syndromes and Biomarkers with Prof. Günter Höglinger and Dr Ed Jabbari on Wednesday. Kailash Bhatia, UCL Queen Square Institute of Neurology MovementDisordersUCL Clinical and Movement Neurosciences @ UCL IoN

Fahr’s Disease is a rare neurodegenerative condition marked by abnormal calcium deposits in the brain. It can cause movement disorders, dementia, psychiatric symptoms, and more. Most people have never heard of it— let's change that. #FahrsDisease #RareDiseaseAwareness #Parkinsons

We developed a new PSD-based approach to characterize tremor & cortical myoclonus. OT, ET, DT & myoclonus form a spectrum of movement regularity. Combined PSD features differentiate conditions and distinguish ET from DT. Clinical and Movement Neurosciences @ UCL IoN UCL Queen Square Institute of Neurology Movement Disorders Journal …mentdisorders.onlinelibrary.wiley.com/doi/full/10.10…

PhD opportunity for clinicians with myself and Sonia Gandhi Gandhi_Lab The Francis Crick Institute working on Multiscale Modelling in Parkinson’s. Details here: crick.ac.uk/careers-study/… Neurology Trainees MovementDisordersUCL #parkinsons

The Association of Medical Research Charities (AMRC) is the membership organisation for leading medical and health research charities in the UK. We are pleased to share this infographic, which highlights the findings from their recent report.

"I can not live in my specialist bubble" . What to do ? Adopt a "rehabilitative attitude", by establishing a different relationship with patients and "becoming a particular kind of generalist". Brillant #mdscongress Presidential lecture by Prof. Mark Edwards (King's College London) 👏

The famous MDS video challenge is happening now in the HawaiiConventionCtr, chaired by Kailash Bhatia, and Tony Lang 👑

Wonderful opportunity at WCN Congress Seoul, South Korea #wcn2025 Disparities in Movement Disorders Kailash Bhatia, MDS Professor Tissa Wijeratne OAM MD PhD Nepalese Academy of Neurology World Federation of Neurology (WFN)

An interesting observation from Prof Kailash Bhatia, et al. #FrozenAddicts

Do you know what a ‘deceptive placebo’ is and how it might shape neurological care? A placebo is an inactive treatment that can improve symptoms through psychological and neurobiological mechanisms like expectation and conditioning. Huys and colleagues describe in a new paper in

💊 Today marks the start of the CALCIFADE trial for patients with brain calcification in the UK at UCLH MovementDisordersUCL Clinical and Movement Neurosciences @ UCL IoN UCL Queen Square Institute of Neurology after our collaborative efforts with the leading centre in the Netherlands Amit Batla Kailash Bhatia, FahrBeyond ℹ️ clinicaltrialsregister.eu/ctr-search/tri…

MSA News is out now! Your autumn edition includes articles on Oral Hygiene, support for Carers and volunteering at the trust. Look out for it in your inboxes and on doorsteps from today. You can find all editions of MSA News here - msatrust.org.uk/support-for-yo…